COVID-19 Impact on Global Uterine Fibroids Treatment Market Size, Status and Forecast 2020-2026

September 2020 | 97 pages | ID: CC7641B010A0EN
QYResearch

Abstracts

This report focuses on the global Uterine Fibroids Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Uterine Fibroids Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Blue Endo
• Boston Scientific Corporation
• Cooper Surgical
• Acessa Health, Inc.
• Karl Storz
• LiNA Medical
• Merit Medical Systems
• Olympus Corporation

Market segment by Type, the product can be split into

• Endometrial Ablation
• MRI Guided Procedures
• Hysterectomy
• Myomectomy
• Uterine Artery Embolization
• Radiofrequency Ablation
• Others

Market segment by Application, split into

• Hospitals
• Ambulatory Surgical Centers
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Uterine Fibroids Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Uterine Fibroids Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Uterine Fibroids Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Uterine Fibroids Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Uterine Fibroids Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Endometrial Ablation
  1.4.3 MRI Guided Procedures
  1.4.4 Hysterectomy
  1.4.5 Myomectomy
  1.4.6 Uterine Artery Embolization
  1.4.7 Radiofrequency Ablation
  1.4.8 Others
1.5 Market by Application
  1.5.1 Global Uterine Fibroids Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Ambulatory Surgical Centers
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Uterine Fibroids Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Uterine Fibroids Treatment Industry
    1.6.1.1 Uterine Fibroids Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Uterine Fibroids Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Uterine Fibroids Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Uterine Fibroids Treatment Market Perspective (2015-2026)
2.2 Uterine Fibroids Treatment Growth Trends by Regions
  2.2.1 Uterine Fibroids Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Uterine Fibroids Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Uterine Fibroids Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Uterine Fibroids Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Uterine Fibroids Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Uterine Fibroids Treatment Players by Market Size
  3.1.1 Global Top Uterine Fibroids Treatment Players by Revenue (2015-2020)
  3.1.2 Global Uterine Fibroids Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Uterine Fibroids Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Uterine Fibroids Treatment Market Concentration Ratio
  3.2.1 Global Uterine Fibroids Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Uterine Fibroids Treatment Revenue in 2019
3.3 Uterine Fibroids Treatment Key Players Head office and Area Served
3.4 Key Players Uterine Fibroids Treatment Product Solution and Service
3.5 Date of Enter into Uterine Fibroids Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Uterine Fibroids Treatment Historic Market Size by Type (2015-2020)
4.2 Global Uterine Fibroids Treatment Forecasted Market Size by Type (2021-2026)

5 UTERINE FIBROIDS TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Uterine Fibroids Treatment Market Size by Application (2015-2020)
5.2 Global Uterine Fibroids Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Uterine Fibroids Treatment Market Size (2015-2020)
6.2 Uterine Fibroids Treatment Key Players in North America (2019-2020)
6.3 North America Uterine Fibroids Treatment Market Size by Type (2015-2020)
6.4 North America Uterine Fibroids Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Uterine Fibroids Treatment Market Size (2015-2020)
7.2 Uterine Fibroids Treatment Key Players in Europe (2019-2020)
7.3 Europe Uterine Fibroids Treatment Market Size by Type (2015-2020)
7.4 Europe Uterine Fibroids Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Uterine Fibroids Treatment Market Size (2015-2020)
8.2 Uterine Fibroids Treatment Key Players in China (2019-2020)
8.3 China Uterine Fibroids Treatment Market Size by Type (2015-2020)
8.4 China Uterine Fibroids Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Uterine Fibroids Treatment Market Size (2015-2020)
9.2 Uterine Fibroids Treatment Key Players in Japan (2019-2020)
9.3 Japan Uterine Fibroids Treatment Market Size by Type (2015-2020)
9.4 Japan Uterine Fibroids Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Uterine Fibroids Treatment Market Size (2015-2020)
10.2 Uterine Fibroids Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Uterine Fibroids Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Uterine Fibroids Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Uterine Fibroids Treatment Market Size (2015-2020)
11.2 Uterine Fibroids Treatment Key Players in India (2019-2020)
11.3 India Uterine Fibroids Treatment Market Size by Type (2015-2020)
11.4 India Uterine Fibroids Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Uterine Fibroids Treatment Market Size (2015-2020)
12.2 Uterine Fibroids Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Uterine Fibroids Treatment Market Size by Type (2015-2020)
12.4 Central & South America Uterine Fibroids Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Blue Endo
  13.1.1 Blue Endo Company Details
  13.1.2 Blue Endo Business Overview and Its Total Revenue
  13.1.3 Blue Endo Uterine Fibroids Treatment Introduction
  13.1.4 Blue Endo Revenue in Uterine Fibroids Treatment Business (2015-2020))
  13.1.5 Blue Endo Recent Development
13.2 Boston Scientific Corporation
  13.2.1 Boston Scientific Corporation Company Details
  13.2.2 Boston Scientific Corporation Business Overview and Its Total Revenue
  13.2.3 Boston Scientific Corporation Uterine Fibroids Treatment Introduction
  13.2.4 Boston Scientific Corporation Revenue in Uterine Fibroids Treatment Business (2015-2020)
  13.2.5 Boston Scientific Corporation Recent Development
13.3 Cooper Surgical
  13.3.1 Cooper Surgical Company Details
  13.3.2 Cooper Surgical Business Overview and Its Total Revenue
  13.3.3 Cooper Surgical Uterine Fibroids Treatment Introduction
  13.3.4 Cooper Surgical Revenue in Uterine Fibroids Treatment Business (2015-2020)
  13.3.5 Cooper Surgical Recent Development
13.4 Acessa Health, Inc.
  13.4.1 Acessa Health, Inc. Company Details
  13.4.2 Acessa Health, Inc. Business Overview and Its Total Revenue
  13.4.3 Acessa Health, Inc. Uterine Fibroids Treatment Introduction
  13.4.4 Acessa Health, Inc. Revenue in Uterine Fibroids Treatment Business (2015-2020)
  13.4.5 Acessa Health, Inc. Recent Development
13.5 Karl Storz
  13.5.1 Karl Storz Company Details
  13.5.2 Karl Storz Business Overview and Its Total Revenue
  13.5.3 Karl Storz Uterine Fibroids Treatment Introduction
  13.5.4 Karl Storz Revenue in Uterine Fibroids Treatment Business (2015-2020)
  13.5.5 Karl Storz Recent Development
13.6 LiNA Medical
  13.6.1 LiNA Medical Company Details
  13.6.2 LiNA Medical Business Overview and Its Total Revenue
  13.6.3 LiNA Medical Uterine Fibroids Treatment Introduction
  13.6.4 LiNA Medical Revenue in Uterine Fibroids Treatment Business (2015-2020)
  13.6.5 LiNA Medical Recent Development
13.7 Merit Medical Systems
  13.7.1 Merit Medical Systems Company Details
  13.7.2 Merit Medical Systems Business Overview and Its Total Revenue
  13.7.3 Merit Medical Systems Uterine Fibroids Treatment Introduction
  13.7.4 Merit Medical Systems Revenue in Uterine Fibroids Treatment Business (2015-2020)
  13.7.5 Merit Medical Systems Recent Development
13.8 Olympus Corporation
  13.8.1 Olympus Corporation Company Details
  13.8.2 Olympus Corporation Business Overview and Its Total Revenue
  13.8.3 Olympus Corporation Uterine Fibroids Treatment Introduction
  13.8.4 Olympus Corporation Revenue in Uterine Fibroids Treatment Business (2015-2020)
  13.8.5 Olympus Corporation Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Uterine Fibroids Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Uterine Fibroids Treatment Revenue
Table 3. Ranking of Global Top Uterine Fibroids Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Uterine Fibroids Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Endometrial Ablation
Table 6. Key Players of MRI Guided Procedures
Table 7. Key Players of Hysterectomy
Table 8. Key Players of Myomectomy
Table 9. Key Players of Uterine Artery Embolization
Table 10. Key Players of Radiofrequency Ablation
Table 11. Key Players of Others
Table 12. COVID-19 Impact Global Market: (Four Uterine Fibroids Treatment Market Size Forecast Scenarios)
Table 13. Opportunities and Trends for Uterine Fibroids Treatment Players in the COVID-19 Landscape
Table 14. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 15. Key Regions/Countries Measures against Covid-19 Impact
Table 16. Proposal for Uterine Fibroids Treatment Players to Combat Covid-19 Impact
Table 17. Global Uterine Fibroids Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 18. Global Uterine Fibroids Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 19. Global Uterine Fibroids Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 20. Global Uterine Fibroids Treatment Market Share by Regions (2015-2020)
Table 21. Global Uterine Fibroids Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 22. Global Uterine Fibroids Treatment Market Share by Regions (2021-2026)
Table 23. Market Top Trends
Table 24. Key Drivers: Impact Analysis
Table 25. Key Challenges
Table 26. Uterine Fibroids Treatment Market Growth Strategy
Table 27. Main Points Interviewed from Key Uterine Fibroids Treatment Players
Table 28. Global Uterine Fibroids Treatment Revenue by Players (2015-2020) (Million US$)
Table 29. Global Uterine Fibroids Treatment Market Share by Players (2015-2020)
Table 30. Global Top Uterine Fibroids Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Uterine Fibroids Treatment as of 2019)
Table 31. Global Uterine Fibroids Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 32. Key Players Headquarters and Area Served
Table 33. Key Players Uterine Fibroids Treatment Product Solution and Service
Table 34. Date of Enter into Uterine Fibroids Treatment Market
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Uterine Fibroids Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. Global Uterine Fibroids Treatment Market Size Share by Type (2015-2020)
Table 38. Global Uterine Fibroids Treatment Revenue Market Share by Type (2021-2026)
Table 39. Global Uterine Fibroids Treatment Market Size Share by Application (2015-2020)
Table 40. Global Uterine Fibroids Treatment Market Size by Application (2015-2020) (Million US$)
Table 41. Global Uterine Fibroids Treatment Market Size Share by Application (2021-2026)
Table 42. North America Key Players Uterine Fibroids Treatment Revenue (2019-2020) (Million US$)
Table 43. North America Key Players Uterine Fibroids Treatment Market Share (2019-2020)
Table 44. North America Uterine Fibroids Treatment Market Size by Type (2015-2020) (Million US$)
Table 45. North America Uterine Fibroids Treatment Market Share by Type (2015-2020)
Table 46. North America Uterine Fibroids Treatment Market Size by Application (2015-2020) (Million US$)
Table 47. North America Uterine Fibroids Treatment Market Share by Application (2015-2020)
Table 48. Europe Key Players Uterine Fibroids Treatment Revenue (2019-2020) (Million US$)
Table 49. Europe Key Players Uterine Fibroids Treatment Market Share (2019-2020)
Table 50. Europe Uterine Fibroids Treatment Market Size by Type (2015-2020) (Million US$)
Table 51. Europe Uterine Fibroids Treatment Market Share by Type (2015-2020)
Table 52. Europe Uterine Fibroids Treatment Market Size by Application (2015-2020) (Million US$)
Table 53. Europe Uterine Fibroids Treatment Market Share by Application (2015-2020)
Table 54. China Key Players Uterine Fibroids Treatment Revenue (2019-2020) (Million US$)
Table 55. China Key Players Uterine Fibroids Treatment Market Share (2019-2020)
Table 56. China Uterine Fibroids Treatment Market Size by Type (2015-2020) (Million US$)
Table 57. China Uterine Fibroids Treatment Market Share by Type (2015-2020)
Table 58. China Uterine Fibroids Treatment Market Size by Application (2015-2020) (Million US$)
Table 59. China Uterine Fibroids Treatment Market Share by Application (2015-2020)
Table 60. Japan Key Players Uterine Fibroids Treatment Revenue (2019-2020) (Million US$)
Table 61. Japan Key Players Uterine Fibroids Treatment Market Share (2019-2020)
Table 62. Japan Uterine Fibroids Treatment Market Size by Type (2015-2020) (Million US$)
Table 63. Japan Uterine Fibroids Treatment Market Share by Type (2015-2020)
Table 64. Japan Uterine Fibroids Treatment Market Size by Application (2015-2020) (Million US$)
Table 65. Japan Uterine Fibroids Treatment Market Share by Application (2015-2020)
Table 66. Southeast Asia Key Players Uterine Fibroids Treatment Revenue (2019-2020) (Million US$)
Table 67. Southeast Asia Key Players Uterine Fibroids Treatment Market Share (2019-2020)
Table 68. Southeast Asia Uterine Fibroids Treatment Market Size by Type (2015-2020) (Million US$)
Table 69. Southeast Asia Uterine Fibroids Treatment Market Share by Type (2015-2020)
Table 70. Southeast Asia Uterine Fibroids Treatment Market Size by Application (2015-2020) (Million US$)
Table 71. Southeast Asia Uterine Fibroids Treatment Market Share by Application (2015-2020)
Table 72. India Key Players Uterine Fibroids Treatment Revenue (2019-2020) (Million US$)
Table 73. India Key Players Uterine Fibroids Treatment Market Share (2019-2020)
Table 74. India Uterine Fibroids Treatment Market Size by Type (2015-2020) (Million US$)
Table 75. India Uterine Fibroids Treatment Market Share by Type (2015-2020)
Table 76. India Uterine Fibroids Treatment Market Size by Application (2015-2020) (Million US$)
Table 77. India Uterine Fibroids Treatment Market Share by Application (2015-2020)
Table 78. Central & South America Key Players Uterine Fibroids Treatment Revenue (2019-2020) (Million US$)
Table 79. Central & South America Key Players Uterine Fibroids Treatment Market Share (2019-2020)
Table 80. Central & South America Uterine Fibroids Treatment Market Size by Type (2015-2020) (Million US$)
Table 81. Central & South America Uterine Fibroids Treatment Market Share by Type (2015-2020)
Table 82. Central & South America Uterine Fibroids Treatment Market Size by Application (2015-2020) (Million US$)
Table 83. Central & South America Uterine Fibroids Treatment Market Share by Application (2015-2020)
Table 84. Blue Endo Company Details
Table 85. Blue Endo Business Overview
Table 86. Blue Endo Product
Table 87. Blue Endo Revenue in Uterine Fibroids Treatment Business (2015-2020) (Million US$)
Table 88. Blue Endo Recent Development
Table 89. Boston Scientific Corporation Company Details
Table 90. Boston Scientific Corporation Business Overview
Table 91. Boston Scientific Corporation Product
Table 92. Boston Scientific Corporation Revenue in Uterine Fibroids Treatment Business (2015-2020) (Million US$)
Table 93. Boston Scientific Corporation Recent Development
Table 94. Cooper Surgical Company Details
Table 95. Cooper Surgical Business Overview
Table 96. Cooper Surgical Product
Table 97. Cooper Surgical Revenue in Uterine Fibroids Treatment Business (2015-2020) (Million US$)
Table 98. Cooper Surgical Recent Development
Table 99. Acessa Health, Inc. Company Details
Table 100. Acessa Health, Inc. Business Overview
Table 101. Acessa Health, Inc. Product
Table 102. Acessa Health, Inc. Revenue in Uterine Fibroids Treatment Business (2015-2020) (Million US$)
Table 103. Acessa Health, Inc. Recent Development
Table 104. Karl Storz Company Details
Table 105. Karl Storz Business Overview
Table 106. Karl Storz Product
Table 107. Karl Storz Revenue in Uterine Fibroids Treatment Business (2015-2020) (Million US$)
Table 108. Karl Storz Recent Development
Table 109. LiNA Medical Company Details
Table 110. LiNA Medical Business Overview
Table 111. LiNA Medical Product
Table 112. LiNA Medical Revenue in Uterine Fibroids Treatment Business (2015-2020) (Million US$)
Table 113. LiNA Medical Recent Development
Table 114. Merit Medical Systems Company Details
Table 115. Merit Medical Systems Business Overview
Table 116. Merit Medical Systems Product
Table 117. Merit Medical Systems Revenue in Uterine Fibroids Treatment Business (2015-2020) (Million US$)
Table 118. Merit Medical Systems Recent Development
Table 119. Olympus Corporation Business Overview
Table 120. Olympus Corporation Product
Table 121. Olympus Corporation Company Details
Table 122. Olympus Corporation Revenue in Uterine Fibroids Treatment Business (2015-2020) (Million US$)
Table 123. Olympus Corporation Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Uterine Fibroids Treatment Market Share by Type: 2020 VS 2026
Figure 2. Endometrial Ablation Features
Figure 3. MRI Guided Procedures Features
Figure 4. Hysterectomy Features
Figure 5. Myomectomy Features
Figure 6. Uterine Artery Embolization Features
Figure 7. Radiofrequency Ablation Features
Figure 8. Others Features
Figure 9. Global Uterine Fibroids Treatment Market Share by Application: 2020 VS 2026
Figure 10. Hospitals Case Studies
Figure 11. Ambulatory Surgical Centers Case Studies
Figure 12. Others Case Studies
Figure 13. Uterine Fibroids Treatment Report Years Considered
Figure 14. Global Uterine Fibroids Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Uterine Fibroids Treatment Market Share by Regions: 2020 VS 2026
Figure 16. Global Uterine Fibroids Treatment Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Uterine Fibroids Treatment Market Share by Players in 2019
Figure 19. Global Top Uterine Fibroids Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Uterine Fibroids Treatment as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Uterine Fibroids Treatment Revenue in 2019
Figure 21. North America Uterine Fibroids Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Uterine Fibroids Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Uterine Fibroids Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Uterine Fibroids Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Uterine Fibroids Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Uterine Fibroids Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Uterine Fibroids Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Blue Endo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Blue Endo Revenue Growth Rate in Uterine Fibroids Treatment Business (2015-2020)
Figure 30. Boston Scientific Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Boston Scientific Corporation Revenue Growth Rate in Uterine Fibroids Treatment Business (2015-2020)
Figure 32. Cooper Surgical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Cooper Surgical Revenue Growth Rate in Uterine Fibroids Treatment Business (2015-2020)
Figure 34. Acessa Health, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Acessa Health, Inc. Revenue Growth Rate in Uterine Fibroids Treatment Business (2015-2020)
Figure 36. Karl Storz Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Karl Storz Revenue Growth Rate in Uterine Fibroids Treatment Business (2015-2020)
Figure 38. LiNA Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. LiNA Medical Revenue Growth Rate in Uterine Fibroids Treatment Business (2015-2020)
Figure 40. Merit Medical Systems Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Merit Medical Systems Revenue Growth Rate in Uterine Fibroids Treatment Business (2015-2020)
Figure 42. Olympus Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Olympus Corporation Revenue Growth Rate in Uterine Fibroids Treatment Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed